COMPOSES A ACTIVITE ANTITUMORALE CONTRE DES CELLULES CANCEREUSES PORTEUSES DE MUTATIONS EGFR OU HER2 EXON 20

• 收藏
• 分享

专利权人:

THE UNIVERSITY OF TEXAS SYSTEM;BOARD OF REGENTS

发明人:

ROBICHAUX, JACQULYNE,NILSSON, MONIQUE,HEYMACH, JOHN V.

申请号：

CA3044432

公开号：

CA3044432A1

申请日:

2017.11.17

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present disclosure provides methods of treating cancer in a patient determined to have an EGFR and/or HER2 exon 20 mutation, such as an insertion mutation, by administering a third-generation tyrosine kinase inhibitor, such as poziotinib or afatinib.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/